Casandra
Casandra Test Code QD10058Version 1 (DRAFT)
Performing Lab
Mirtazapine, Serum/Plasma
Clinical Use
Order TestUse
Therapeutic drug monitoring of mirtazapine (Remeron), an antidepressant, to assess serum or plasma drug levels for patient treatment and dosage adjustment.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Other
Biomarkers
Mirtazapine (Remeron)
AnalyteMirtazapine (Remeron) • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
LOINC Codes
Order Codes
- 17283‑3
Result Codes
- 17283‑3
Result Turnaround Time
10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
3 mL
Minimum Volume
1.2 mL
Container
plastic screw‑capped vial
Collection Instructions
Promptly centrifuge and separate serum or plasma into a plastic screw‑capped vial.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Related Tests
Other tests from different labs that may be relevant
Mirtazapine (Remeron)
Mayo Clinic Lab
Mirtazapine, Serum or Plasma
Labcorp
Trimipramine, Serum or Plasma
Labcorp
Thioridazine and Mesoridazine, Serum or Plasma
Labcorp
Paroxetine, Serum or Plasma
Labcorp
Trazodone
Labcorp
Trazodone, Serum/Plasma
ARUP Laboratories
Amitriptyline and Nortriptyline, Serum or Plasma
ARUP Laboratories
Mesoridazine, Serum or Plasma
Labcorp
Clomipramine and Metabolite, Serum or Plasma
ARUP Laboratories